Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Neurosci Lett ; 653: 208-214, 2017 Jul 13.
Article in English | MEDLINE | ID: mdl-28576564

ABSTRACT

Several studies reported that stress can enhance the consumption of alcohol in humans and animals. However, the combinatorial effect of stress and alcohol on cognitive function and neurochemical alterations is quite understudied. In the present study, we have elucidated the involvement of oxidative stress-PARP cascade in alcohol and restraint stress (RS)-exposed animals using a PARP inhibitor, 1,5-isoquinolinediol (3mg/kg for 14days). Male Swiss albino mice were given alcohol (ALC) or RS (2h per day) or both in ALC+RS group for 28days. Behavioral analysis revealed cognitive dysfunction in ALC+RS group. Furthermore, oxidative stress and raised level of pro-inflammatory cytokines were found in the hippocampus region of ALC+RS group. Semi-quantitative reverse transcriptase PCR showed overactivation of PARP-1 gene in ALC+RS group. 1,5-isoquinolinediol treatment significantly prevented cognitive deficits and aforementioned neurochemical alterations. Overall, our findings showed that ALC+RS exerted deleterious effects on the hippocampus which involves oxidative stress-PARP overactivation cascade.


Subject(s)
Cognitive Dysfunction/etiology , Ethanol/administration & dosage , Hippocampus/metabolism , Oxidative Stress , Poly (ADP-Ribose) Polymerase-1/metabolism , Stress, Psychological/metabolism , Animals , Cognitive Dysfunction/chemically induced , Cognitive Dysfunction/enzymology , Encephalitis/complications , Encephalitis/metabolism , Hippocampus/drug effects , Hippocampus/physiopathology , Interleukin-1beta/metabolism , Male , Mice , Poly (ADP-Ribose) Polymerase-1/antagonists & inhibitors , Poly(ADP-ribose) Polymerase Inhibitors/administration & dosage , Restraint, Physical , Stress, Psychological/complications
2.
Cell Mol Neurobiol ; 37(1): 65-81, 2017 Jan.
Article in English | MEDLINE | ID: mdl-26886752

ABSTRACT

Chronic stress exposure can produce deleterious effects on the hippocampus (HC) which eventually leads to cognitive impairment and depression. Endoplasmic reticulum (ER) stress has been reported as one of the major culprits in the development of stress-induced cognitive impairment and depression. We investigated the neuroprotective efficacy of sodium phenylbutyrate (SPB), an ER stress inhibitor, and edaravone, a free radical scavenger, against chronic restraint stress (CRS)-induced cognitive deficits and anxiety- and depressive-like behavior in mice. Adult male Swiss albino mice were restrained for 6 h/day for 28 days and injected (i.p.) with SPB (40 and 120 mg/kg) or edaravone (3 and 10 mg/kg) for the last seven days. After stress cessation, the anxiety- and depressive-like behavior along with spatial learning and memory were examined. Furthermore, oxido-nitrosative stress, proinflammatory cytokines, and gene expression level of ER stress-related genes were assessed in HC and prefrontal cortex (PFC). CRS-exposed mice showed anxiety- and depressive-like behavior, which was significantly improved by SPB and edaravone treatment. In addition, SPB and edaravone treatment significantly alleviated CRS-induced spatial learning and memory impairment. Furthermore, CRS-evoked oxido-nitrosative stress, neuroinflammation, and depletion of Brain-derived neurotrophic factor were significantly ameliorated by SPB and edaravone treatment. We found significant up-regulation of ER stress-related genes in both HC and PFC regions, which were suppressed by SPB and edaravone treatment in CRS mice. Our study provides evidence that SPB and edaravone exerted neuroprotective effects on CRS-induced cognitive deficits and anxiety- and depressive-like behavior, which is possibly coupled with inhibition of oxido-nitrosative stress, neuroinflammation, and ER stress cascade.


Subject(s)
Antipyrine/analogs & derivatives , Depression/drug therapy , Endoplasmic Reticulum Stress/drug effects , Oxidative Stress/drug effects , Phenylbutyrates/therapeutic use , Stress, Psychological/drug therapy , Animals , Antipyrine/pharmacology , Antipyrine/therapeutic use , Chronic Disease , Depression/etiology , Depression/metabolism , Dose-Response Relationship, Drug , Edaravone , Endoplasmic Reticulum Stress/physiology , Free Radical Scavengers/pharmacology , Free Radical Scavengers/therapeutic use , Inflammation/drug therapy , Inflammation/metabolism , Male , Mice , Nitrosation/drug effects , Nitrosation/physiology , Oxidative Stress/physiology , Phenylbutyrates/pharmacology , Restraint, Physical , Stress, Psychological/complications , Stress, Psychological/metabolism
3.
Physiol Behav ; 154: 135-44, 2016 Feb 01.
Article in English | MEDLINE | ID: mdl-26522738

ABSTRACT

Poly(ADP-ribose) polymerase-1 (PARP-1) is a DNA nick-sensor enzyme that functions at the center of cellular stress response and affects the immune system at several key points, and thus modulates inflammatory diseases. Our previous study demonstrated that lipopolysaccharide (LPS)-induced depressive-like behavior in mice can be ameliorated by 3-aminobenzamide, which is a PARP-1 inhibitor. In the present study we've examined the effect of a free radical scavenger, edaravone pretreatment against LPS-induced anxiety and depressive-like behavior as well as various hippocampal biochemical parameters including PARP-1. Male Swiss albino mice were treated with edaravone (3 & 10mg/kgi.p.) once daily for 14days. On the 14th day 30min after edaravone treatment mice were challenged with LPS (1mg/kgi.p.). After 3h and 24h of LPS administration we've tested mice for anxiety and depressive-like behaviors respectively. Western blotting analysis of PARP-1 in hippocampus was carried out after 12h of LPS administration. Moreover, after 24h of LPS administration serum corticosterone, hippocampal BDNF, oxido-nitrosative stress and pro-inflammatory cytokines were estimated by ELISA. Results showed that pretreatment of edaravone (10mg/kg) ameliorates LPS-induced anxiety and depressive-like behavior. Western blotting analysis showed that LPS-induced anomalous expression of PARP-1 significantly reverses by the pretreatment of edaravone (10mg/kg). Biochemical analyses revealed that LPS significantly diminishes BDNF, increases pro-inflammatory cytokines and oxido-nitrosative stress in the hippocampus. However, pretreatment with edaravone (10mg/kg) prominently reversed all these biochemical alterations. Our study emphasized that edaravone pretreatment prevents LPS-induced anxiety and depressive-like behavior, mainly by impeding the inflammation, oxido-nitrosative stress and PARP-1 overexpression.


Subject(s)
Antipyrine/analogs & derivatives , Encephalitis/drug therapy , Free Radical Scavengers/therapeutic use , Mental Disorders/drug therapy , Poly(ADP-ribose) Polymerases/metabolism , Adaptation, Ocular/drug effects , Animals , Antipyrine/therapeutic use , Anxiety/chemically induced , Anxiety/drug therapy , Catalase/metabolism , Disease Models, Animal , Dose-Response Relationship, Drug , Edaravone , Encephalitis/chemically induced , Exploratory Behavior/drug effects , Glutathione/metabolism , Hindlimb Suspension , Lipopolysaccharides/toxicity , Male , Maze Learning/drug effects , Mental Disorders/chemically induced , Mice , Poly (ADP-Ribose) Polymerase-1 , Superoxide Dismutase/metabolism , Swimming/psychology
4.
Neurosci Lett ; 611: 106-11, 2016 Jan 12.
Article in English | MEDLINE | ID: mdl-26620836

ABSTRACT

Inflammation and oxidative stress are involved in the pathophysiology of anxiety and depression. Esculetin (ESC), a coumarin derived potent antioxidant, also possessing anti-inflammatory and neuroprotective activity. This study investigated the effect of ESC in lipopolysaccharide (LPS)-induced anxiety- and depressive-like behaviour in mice. ESC (25 and 50mg/kg, p.o.) was administered daily for 14 days, and challenged with saline or LPS (0.83mg/kg; i.p.) on the 15th day. Behavioural paradigms such as elevated plus maze (EPM), open field test (OFT), forced swim test (FST) and tail suspension test (TST) were employed to assess anxiety- and depressive-like behaviour in mice post-LPS injection. Hippocampal cytokines, MDA and GSH level, and plasma corticosterone (CORT) were measured. ESC pre-treatment significantly (P<0.05) attenuated LPS-induced anxiety-like behaviour by modulating EPM and OFT parameters. Moreover, LPS-induced increase in immobility time in FST and TST were also prevented significantly (P<0.05) by ESC (50mg/kg). ESC pre-treatment ameliorated LPS-induced neuroinflammation by attenuating brain IL-1ß, IL-6, TNF-α level, and oxidative stress as well as plasma CORT level. In conclusion, the results suggest that ESC prevented LPS-induced anxiety- and depressive-like behaviour which may be governed by inhibition of cytokine production, oxidative stress and plasma CORT level. The results support the potential usefulness of ESC in the treatment of psychiatric disorders associated with inflammation and oxidative stress.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Antioxidants/pharmacology , Anxiety/prevention & control , Depression/prevention & control , Lipopolysaccharides/pharmacology , Umbelliferones/pharmacology , Animals , Anti-Inflammatory Agents/therapeutic use , Antioxidants/therapeutic use , Anxiety/chemically induced , Anxiety/psychology , Behavior, Animal/drug effects , Corticosterone/blood , Depression/chemically induced , Depression/psychology , Hippocampus/drug effects , Hippocampus/metabolism , Interleukin-1beta/metabolism , Interleukin-6/metabolism , Male , Mice , Oxidative Stress , Tumor Necrosis Factor-alpha/metabolism , Umbelliferones/therapeutic use
5.
Eur J Pharmacol ; 770: 25-32, 2016 Jan 05.
Article in English | MEDLINE | ID: mdl-26638996

ABSTRACT

The primary objective of our study is to investigate the neuroprotective efficacy of honokiol and imipramine against restraint stress (RS)-induced cognitive impairment and depressive-like behaviour in mice. We examined whether the neuroprotective activity of honokiol and imipramine mediates through the inhibition of endoplasmic reticulum stress. Adult Swiss albino mice were restrained for 6h/day for 28 days. Honokiol (3 and 10mg/kg) and Imipramine (10 and 30mg/kg) were administered for last 7 days to the different groups. Cognitive function was assessed by Morris water maze and novel object recognition test. Forced swimming test and tail suspension test were performed to evaluate the restraint stress-induced depressive-like behaviour. Proinflammatory cytokines, brain-derived neurotrophic factor, and ER stress markers i.e. 78-kDa glucose-regulated protein (GRP78) and C/EBP homologous protein (CHOP) were quantified in the hippocampus. We observed cognitive impairment and depressive-like behaviour in RS-exposed animals. Honokiol (10mg/kg) treated group depicted marked reduction in cognitive impairment and depressive-like behaviour. However, imipramine (10 and 30mg/kg) prevented the depressive-like behaviour but failed to prevent RS-induced cognitive impairment. Moreover, proinflammatory cytokines, GRP78 and CHOP were elevated in the hippocampus of stressed mice as compared to unstressed mice. Honokiol (10mg/kg) significantly prevented the RS-induced elevated levels of proinflammatory cytokines and endoplasmic reticulum stress markers. Our results clearly suggest the beneficial potential of honokiol in restraint stress through inhibition of proinflammatory cytokines and endoplasmic reticulum stress. Honokiol could be an intriguing therapeutic approach in endoplasmic reticulum stress related neuro-pathophysiological conditions.


Subject(s)
Behavior, Animal/drug effects , Biphenyl Compounds/pharmacology , Cognition Disorders/drug therapy , Depression/drug therapy , Endoplasmic Reticulum Stress/drug effects , Hippocampus/drug effects , Lignans/pharmacology , Stress, Psychological/complications , Animals , Biphenyl Compounds/therapeutic use , Brain-Derived Neurotrophic Factor/metabolism , Cognition Disorders/metabolism , Cognition Disorders/pathology , Cognition Disorders/psychology , Cytokines/metabolism , Depression/metabolism , Depression/pathology , Depression/psychology , Endoplasmic Reticulum Chaperone BiP , Gene Expression Regulation/drug effects , Heat-Shock Proteins/genetics , Hippocampus/metabolism , Hippocampus/pathology , Hippocampus/physiopathology , Imipramine/pharmacology , Lignans/therapeutic use , Male , Mice , Restraint, Physical/psychology , Transcription Factor CHOP/genetics
6.
Pharmacol Biochem Behav ; 133: 83-91, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25863272

ABSTRACT

Poly (ADP-ribose) polymerase-1 (PARP-1) functions at the center of cellular stress and sways the immune system at several key points, thus modulates inflammatory diseases. The antiinflammatory properties of PARP-1 inhibitors have been demonstrated ameliorating effect in various neuroinflammatory disorders. It has been reported that there is a close relationship between the inflammatory processes and major depressive disorder. In the present study, we have elucidated the role of oxidative-nitrosative stress-PARP-1 pathway in lipopolysaccharide (LPS)-induced neurobehavioral and neurochemical alterations in mice. 3-Aminobenzamide (10 and 30mg/kg) and imipramine (10 and 30mg/kg) were administered once daily for 14days. Mice were challenged with LPS (1mg/kg, i.p.) 30min after drug administration on the 14th day. The mRNA expression level of PARP-1 (12h after LPS injection) in the hippocampus was measured through quantitative real-time PCR. All the behavioral and biochemical parameters were assessed at 24h after LPS injection. The expression level of PARP-1mRNA was found significantly up-regulated in the hippocampus at 12h after LPS administration. Results showed that the LPS-challenged mice exhibited an increase in immobility time seen in forced swimming test and tail suspension test. LPS increased the levels of proinflammatory cytokines and oxido-nitrosative stress parameters in the hippocampus. However, pretreatment with 3-aminobenzamide (30mg/kg) significantly reversed the LPS-induced alterations in behavioral parameters, proinflammatory cytokines, oxidative-nitrosative stress and PARP-1 mRNA levels. Imipramine failed to prevent the up-regulation of PARP-1 induced by LPS administration. Our results emphasized that oxidative-nitrosative stress-PARP-1 cascade can play a key role in LPS-induced neurobehavioral and neurochemical anomalies.


Subject(s)
Benzamides/pharmacology , Lipopolysaccharides/antagonists & inhibitors , Poly(ADP-ribose) Polymerase Inhibitors/pharmacology , Animals , Catalase/metabolism , Glutathione/metabolism , Hippocampus/metabolism , Imipramine/pharmacology , Immobility Response, Tonic/drug effects , Interleukin-1beta/metabolism , Lipid Peroxidation/drug effects , Lipopolysaccharides/pharmacology , Male , Mice , Motor Activity/drug effects , NAD/metabolism , Nitrites/metabolism , Poly (ADP-Ribose) Polymerase-1 , Poly(ADP-ribose) Polymerases/biosynthesis , Superoxide Dismutase/metabolism , Tumor Necrosis Factor-alpha/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...